Redhill Company Profile
✉ Email this page to a colleague
What is the competitive landscape for REDHILL, and what generic alternatives to REDHILL drugs are available?
REDHILL has two approved drugs.
There are eleven US patents protecting REDHILL drugs.
There are fifty patent family members on REDHILL drugs in thirty-one countries and three supplementary protection certificates in three countries.
Summary for Redhill
| International Patents: | 50 |
| US Patents: | 11 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Redhill
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Redhill | AEMCOLO | rifamycin sodium | TABLET, DELAYED RELEASE;ORAL | 210910-001 | Nov 16, 2018 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Redhill | AEMCOLO | rifamycin sodium | TABLET, DELAYED RELEASE;ORAL | 210910-001 | Nov 16, 2018 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Redhill | TALICIA | amoxicillin; omeprazole magnesium; rifabutin | CAPSULE, DELAYED RELEASE;ORAL | 213004-001 | Nov 1, 2019 | RX | Yes | Yes | 11,878,011 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Redhill | AEMCOLO | rifamycin sodium | TABLET, DELAYED RELEASE;ORAL | 210910-001 | Nov 16, 2018 | DISCN | Yes | No | 8,486,446 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Redhill | TALICIA | amoxicillin; omeprazole magnesium; rifabutin | CAPSULE, DELAYED RELEASE;ORAL | 213004-001 | Nov 1, 2019 | RX | Yes | Yes | 11,135,172 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Redhill | TALICIA | amoxicillin; omeprazole magnesium; rifabutin | CAPSULE, DELAYED RELEASE;ORAL | 213004-001 | Nov 1, 2019 | RX | Yes | Yes | 9,603,806 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Redhill Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Spain | 2303255 | ⤷ Subscribe |
| Serbia | 50581 | ⤷ Subscribe |
| Austria | E392889 | ⤷ Subscribe |
| Finland | C20190031 | ⤷ Subscribe |
| Portugal | 1763339 | ⤷ Subscribe |
| Japan | 5026262 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Redhill Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1763339 | 122019000048 | Germany | ⤷ Subscribe | PRODUCT NAME: RIFAMYCIN SV; NAT. REGISTRATION NO/DATE: 2200986.00.00 20190509; FIRST REGISTRATION: GB PL 08637/0028 20181218 |
| 1763339 | SPC/GB19/037 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: RIFAMYCIN SV; REGISTERED: UK PL08637/0028 20181218 |
| 1763339 | C201930053 | Spain | ⤷ Subscribe | PRODUCT NAME: RIFAMICINA SV; NATIONAL AUTHORISATION NUMBER: 84120-DE/H/5379/001/DC; DATE OF AUTHORISATION: 20190628; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): PL 08637/0028; DATE OF FIRST AUTHORISATION IN EEA: 20181218 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
